Inventor
HOOK DAVID
CH16 patents
⚠️ This page may combine multiple inventors who share the name “HOOK DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HOOK DAVID
13 patentsUS8115016B2Feb 14, 2012
Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
HOOK DAVID13 citations90
US8580974B2Nov 12, 2013
Processes
HOOK DAVID6 citations81
US8835668B2Sep 16, 2014
Process for the preparation of intermediates for the manufacture of NEP inhibitors
HOOK DAVID4 citations71
US9085529B2Jul 21, 2015
Process for the preparation of intermediates useful for the manufacture NEP inhibitors
HOOK DAVID2 citations60
US8993785B2Mar 31, 2015
Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
HOOK DAVID2 citations60
US9061973B2Jun 23, 2015
Processes for producing NEP inhibitors or prodrugs thereof
HOOK DAVID1 citations59
US9067883B2Jun 30, 2015
Intermediates of neutral endopeptidase inhibitors and preparation method thereof
HOOK DAVID2 citations58
US9802887B2Oct 31, 2017
Process for the preparation of intermediates useful for the manufacture NEP inhibitors
HOOK DAVID1 citations50
US9403766B2Aug 2, 2016
Intermediates for producing NEP inhibitors or prodrugs thereof
HOOK DAVID0 citations49
US9227934B2Jan 5, 2016
Processes for producing NEP inhibitors or prodrugs thereof
HOOK DAVID0 citations49
US9206116B2Dec 8, 2015
Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
HOOK DAVID0 citations49
US8716495B2May 6, 2014
Process for preparing 5-biphenyl-4-amino-2-methyl pentanoic acid
HOOK DAVID0 citations49
US9278908B2Mar 8, 2016
Intermediates of neutral endopeptidase inhibitors and preparation method thereof
HOOK DAVID0 citations48
NOVARTIS AG
3 patentsUS11786498B2Oct 17, 2023
Sacubitril calcium salts
NOVARTIS AG0 citations56
US11642315B2May 9, 2023
Method for preparing a pharmaceutical product
NOVARTIS AG0 citations44
US8946481B2Feb 3, 2015
Process for preparing biaryl substituted 4-amino butyric acid or derivatives thereof and their use in the production of NEP inhibitors
NOVARTIS AG0 citations40